BlackRock’s Cyclerion Therapeutics CYCN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$48.9K Hold
16,797
﹤0.01% 4920
2025
Q1
$42K Hold
16,797
﹤0.01% 4903
2024
Q4
$54.1K Hold
16,797
﹤0.01% 4875
2024
Q3
$43.5K Sell
16,797
-372
-2% -$963 ﹤0.01% 4789
2024
Q2
$39.5K Hold
17,169
﹤0.01% 4856
2024
Q1
$54.9K Hold
17,169
﹤0.01% 4792
2023
Q4
$57.5K Sell
17,169
-831
-5% -$2.78K ﹤0.01% 4867
2023
Q3
$61.6K Hold
18,000
﹤0.01% 4898
2023
Q2
$74.2K Sell
18,000
-1
-0% -$4 ﹤0.01% 4911
2023
Q1
$156K Sell
18,001
-14
-0.1% -$121 ﹤0.01% 4762
2022
Q4
$236K Sell
18,015
-19
-0.1% -$249 ﹤0.01% 4720
2022
Q3
$310K Sell
18,034
-45
-0.2% -$774 ﹤0.01% 4770
2022
Q2
$198K Sell
18,079
-3,990
-18% -$43.7K ﹤0.01% 4940
2022
Q1
$490K Sell
22,069
-189
-0.8% -$4.2K ﹤0.01% 4783
2021
Q4
$765K Buy
22,258
+500
+2% +$17.2K ﹤0.01% 4674
2021
Q3
$1.34M Sell
21,758
-49
-0.2% -$3.01K ﹤0.01% 4416
2021
Q2
$1.7M Sell
21,807
-62,467
-74% -$4.87M ﹤0.01% 4275
2021
Q1
$4.7M Buy
84,274
+4,068
+5% +$227K ﹤0.01% 3908
2020
Q4
$4.91M Buy
80,206
+4,039
+5% +$247K ﹤0.01% 3646
2020
Q3
$9.26M Sell
76,167
-2,176
-3% -$265K ﹤0.01% 3181
2020
Q2
$9.26M Sell
78,343
-1,120
-1% -$132K ﹤0.01% 3161
2020
Q1
$4.21M Sell
79,463
-1,371
-2% -$72.7K ﹤0.01% 3365
2019
Q4
$4.4M Buy
80,834
+5,361
+7% +$292K ﹤0.01% 3497
2019
Q3
$18.3M Buy
75,473
+1,586
+2% +$384K ﹤0.01% 2835
2019
Q2
$16.9M Buy
+73,887
New +$16.9M ﹤0.01% 2910